Curtiss-Wright CFO granted 645 RSUs

Farkas K Christopher reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Farkas K Christopher reported acquisition or exercise transactions in this Form 4 filing.

Curtiss-Wright Executive VP and CFO K. Christopher Farkas received a grant of 645 restricted stock units (RSUs) on March 9, 2026. These RSUs were granted as an employee benefit under the company’s 2024 Omnibus Incentive Plan and carry no purchase price.

Each RSU represents a contingent right to receive one share of Curtiss-Wright common stock, with the award cliff vesting after a three-year period from the grant date. Following this grant, Farkas holds 11,549 RSUs in total, a figure that also reflects dividend credits earned on prior outstanding grants.

Insider Trade Summary

Grant/Award: 645 shares

Grant/Award 1 txn

Insider Farkas K Christopher

Role Executive VP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	645	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 11,549 contracts (Direct)

Footnotes (3)

1. F1. This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
2. F2. No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
3. F3. Share total includes dividend credits earned on prior outstanding grants.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Curtiss-Wright (CW) CFO K. Christopher Farkas report on this Form 4?

He reported receiving a grant of 645 restricted stock units as compensation. The RSUs were issued under Curtiss-Wright’s 2024 Omnibus Incentive Plan and represent a contingent right to receive common shares after vesting, rather than an open-market stock purchase.

Is the Curtiss-Wright (CW) CFO’s RSU grant an open-market stock purchase?

No, the 645 restricted stock units were granted as an employee benefit transaction. There was no price on the date of issue, and the award comes from the company’s incentive plan, not from buying shares in the open market.

When do the newly granted RSUs to Curtiss-Wright (CW) CFO vest?

The RSUs will cliff vest after a three-year period from March 9, 2026. This means all 645 units vest at once at the end of the three-year term, rather than vesting gradually over multiple dates.

How many restricted stock units does Curtiss-Wright (CW) CFO hold after this grant?

After this grant, K. Christopher Farkas holds 11,549 restricted stock units. This total includes the newly awarded 645 RSUs as well as dividend credits earned on prior outstanding grants, reflecting his full RSU-based equity position reported here.

What does each Curtiss-Wright (CW) RSU granted to the CFO represent?

Each restricted stock unit represents a contingent right to receive one share of Curtiss-Wright common stock. The units convert into actual shares only upon vesting at the end of the three-year period, assuming any applicable service-based conditions are satisfied.

Under which plan were the Curtiss-Wright (CW) CFO’s RSUs granted?

The 645 RSUs were granted under Curtiss-Wright’s 2024 Omnibus Incentive Plan. This plan is used to deliver equity-based compensation, aligning executive pay with shareholder interests by tying awards to the company’s common stock over multi-year vesting periods.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farkas K Christopher

(Last) (First) (Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	$0(2)	03/09/2026		A		645		03/09/2029	03/09/2029	Common Stock	645	$0(2)	11,549(3)	D

Explanation of Responses:

1. This is a time-based restricted stock unit ("RSU") grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.

2. No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

3. Share total includes dividend credits earned on prior outstanding grants.

Remarks:

	George P. McDonald by Power of Attorney from K. Christopher Farkas	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.